CNR2 and non-small cell lung carcinoma: We report that tumors in CB2-/- mice are smaller than in their WT littermates, and that CB2-/- mice respond better to anti-PD-1 therapy, indicating that CB2 expression in the TME is a critical determinant of immune suppression in this NSCLC model.